| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441183 | European Journal of Cancer | 2016 | 6 Pages |
Abstract
Haematological and cardiovascular toxicities are more frequent in elderly patients. However, this did not influence prior discontinuation of therapy. Elderly patients should not be deprived of adequate chemotherapy or excluded from clinical studies just because of their age. Thorough geriatric assessment and monitoring is mandatory.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
H. Woopen, G. Inci, R. Richter, R. Chekerov, F. Ismaeel, J. Sehouli,